Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Zivanovic

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Gynecologic Oncology|January 11, 2020
Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomesBenny Brandt, Vasileios Sioulas, Derman Basaran, et al.
Gynecologic Oncology|February 22, 2023
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trialAaron M Praiss, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|September 5, 2022
A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenterationEric Rios-Doria, Olga T Filippova, Alli M Straubhar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 10, 2025
Preoperative immunonutrition for patients who undergo primary cytoreductive surgery for ovarian cancerRyan Kahn, Evan Smith, Kimberly Murphy, et al.
Gynecologic Oncology|January 19, 2016
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer centerJennifer J Mueller, Qin C Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|May 23, 2019
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation statusMarina Stasenko, Paulina Cybulska, Noah Feit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2024
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian CarcinomaBeryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|January 11, 2020
Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomesBenny Brandt, Vasileios Sioulas, Derman Basaran, et al.
Gynecologic Oncology|February 22, 2023
Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trialAaron M Praiss, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|September 5, 2022
A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenterationEric Rios-Doria, Olga T Filippova, Alli M Straubhar, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 10, 2025
Preoperative immunonutrition for patients who undergo primary cytoreductive surgery for ovarian cancerRyan Kahn, Evan Smith, Kimberly Murphy, et al.
Gynecologic Oncology|January 19, 2016
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer centerJennifer J Mueller, Qin C Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|May 23, 2019
Brain metastasis in epithelial ovarian cancer by BRCA1/2 mutation statusMarina Stasenko, Paulina Cybulska, Noah Feit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 2024
A pre-operative scoring model to estimate the risk of blood transfusion over an ovarian cancer debulking surgery (BLOODS score): a Memorial Sloan Kettering Cancer Center Team Ovary studyRyan M Kahn, Thomas Boerner, Michael Kim, et al.
Annals of Surgical Oncology|October 30, 2015
Is It Time to Centralize Ovarian Cancer Care in the United States?Renee A Cowan, Roisin E O'Cearbhaill, Ginger J Gardner, et al.
Gynecologic Oncology|November 20, 2020
Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary studyThomas Boerner, Edward Tanner, Olga Filippova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2022
MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian CarcinomaBeryl Manning-Geist, Sushmita Gordhandas, Ying L Liu, et al.
Pageof 21